Heparin therapy in septicemia with disseminated intravascular coagulation.
D000347:Afibrinogenemia / Q000150:complications; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests; D002648:Child; D002675:Child, Preschool; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000209:etiology; D004754:Enterobacter / Q000302:isolation & purification; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006470:Hemorrhage / Q000150:complications; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007022:Hypotension / Q000150:complications; D007223:Infant; D007231:Infant, Newborn; D007919:Leptospira / Q000302:isolation & purification; D008297:Male; D009345:Neisseria meningitidis / Q000302:isolation & purification; D011379:Prognosis; D011517:Prothrombin Time; D011549:Pseudomonas / Q000302:isolation & purification; D018805:Sepsis / Q000150:complications* / Q000382:microbiology / Q000401:mortality; D012772:Shock, Septic / Q000150:complications / Q000401:mortality*; D013210:Staphylococcus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification
D001779:Blood Coagulation Factors; D005340:Fibrinogen; D006493:Heparin